AzTrials
AzTrials

Alcohol-Related DisordersNCT05865847

Socioeconomic Differences in Alcohol Harm in Finland in a Nationwide Cohort Study

An observational study of Alcohol-Related Disorders, run by Finnish Institute for Health and Welfare.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This is a nationwide cohort study of Finnish adults aged 25 and older, who are followed up for the incidence of an alcohol-attributable hospitalization or death. The primary objective is to examine the relative and absolute socioeconomic differences in cause-specific alcohol-attributable hospital admissions and deaths. Read more about this study

Who is it for?
Ages 25 years and olderHealthy volunteers can take part
Conditions the study is for
Alcohol-Related Disorders
What is being tested?
Not applicable, this is an observational study
How many people
3,950,000 participants
Where
No sites listed yet
Study dates
1 Jan 2015to 30 Sep 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: All permanent residents in Finland older than 25 years old and without an alcohol-attributable hospital admission during the past three years

Who may be able to join

  • Permanent residents (defined by Statistics Finland as those Finnish and foreign nationals who have a legal domicile in Finland and intend to stay (or have stayed) for at least one year) alive in Finland by December 31, 2015
  • Age 25 years or older by January 1, 2016
  • Not having an alcohol-attributable hospitalization during the past three years ((January 2013-December 2015

Who cannot join

  • Temporary residents, including foreign nationals living in Finland for less than a year, asylum seekers who have not been granted a legal domicile, temporary migrant workers and Finnish nationals living temporarily abroad by December 31, 2015

About this study

Official title: Unveiling the Alcohol Harm Paradox: Analysis of Socioeconomic Differences in Alcohol Harm in Finland in a Nationwide Cohort Study

This is a nationwide cohort study of Finnish adults aged 25 and older, who are followed up for the incidence of an alcohol-attributable hospitalization or death. The primary objective is to examine the relative and absolute socioeconomic differences in cause-specific alcohol-attributable hospital admissions and deaths.

Read the detailed description

Background

Alcohol consumption is a leading risk factor for death and disability, resulting in substantial societal costs and social and community harm. Alcohol-related harm has been consistently shown to be higher among people of lower socioeconomic status, despite the fact they often report similar or lower levels of alcohol use. This apparent contrast has been called the alcohol harm paradox.

Understanding what explains the alcohol harm paradox is crucial for the design and implementation of population health interventions to reduce socioeconomic differences in alcohol harm. Explanations for the paradox can be broadly categorised into three groups: (i) differential exposure to alcohol, drinking patterns and trajectories and to other behavioural risk factors and joint effects among them, (ii) differential vulnerability resulting from individual factors, such as biological characteristics, psychological traits or stress, cumulative disadvantage and broader community and societal upstream factors, and (iii) differential biases in the measurement of alcohol exposure.

A crucial weakness of existing empirical studies comes from the operationalization of alcohol harm. With few exceptions, a vast majority of studies has used a composite endpoint combining several causes of alcohol-attributable deaths or hospitalizations or even merging alcohol-attributable hospital admissions with deaths in a single outcome. While this strategy increases the statistical power to analyse rare events, composite endpoints are prone to misclassification bias by masking divergent underlying patterns and associations.

Cause-specific analyses might shed light on different mechanisms driving the socioeconomic differences in overall alcohol-attributable harm, as well as opening potential avenues for policy interventions to reduce them. The study will take advantage of a recently formed dataset covering the total Finnish population to explore associations between socioeconomic status and cause-specific alcohol-attributable events. An additional contribution to the literature will be reporting both relative and absolute inequalities in alcohol-attributable harm. Absolute differences have been rarely reported even though might be as relevant as relative differences because, from a pragmatic standpoint, they are more feasible to reduce.

The study will aim to (1) examine the relative and absolute socioeconomic differences in cause-specific alcohol-attributable hospital admissions and deaths; (2) describe the geographical differences in cause-specific alcohol-attributable hospital admissions and deaths; and (3) quantify the relative contribution of each specific alcohol-attributable cause to the overall alcohol-attributable harm.

Being tested
Not applicable, this is an observational study
Medical subject headings
Alcohol-Related Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Not applicable, this is an observational studyOther

    Not applicable, this is an observational study

Study groups in NCT05865847
Study groupRoleWhat they receive
Lowest income groupsDeciles of equivalized net household income. The method compares the whole socioeconomic distribution.
Receives: Other: Not applicable, this is an observational study

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Alcohol intoxication - Hospitalization

    Incidence of alcohol intoxication hospitalization (ICD-10 F10.0-1)

    Measured: January 1, 2016 to February 28, 2020

  2. Alcohol intoxication - Death

    Death due to alcohol intoxication (ICD-10 F10.0-1)

    Measured: January 1, 2016 to February 28, 2020

  3. Alcohol dependence - Hospitalization

    Incidence of hospitalization due to alcohol dependence (F10.2)

    Measured: January 1, 2016 to February 28, 2020

  4. Alcohol dependence - Death

    Death due to alcohol dependence (F10.2)

    Measured: January 1, 2016 to February 28, 2020

  5. Psycho-organic syndrome caused by alcohol - Hospitalization

    Incidence of hospitalization due to psycho-organic syndrome caused by alcohol (F10.3-9)

    Measured: January 1, 2016 to February 28, 2020

  6. Psycho-organic syndrome caused by alcohol - Death

    Death due to psycho-organic syndrome caused by alcohol (F10.3-9)

    Measured: January 1, 2016 to February 28, 2020

  7. Alcoholic liver disease - Hospitalization

    Incidence of hospitalization due to alcoholic liver disease(K70)

    Measured: January 1, 2016 to February 28, 2020

  8. Alcoholic liver disease - Death

    Death due to alcoholic liver disease(K70)

    Measured: January 1, 2016 to February 28, 2020

  9. Pancreatic diseases caused by alcohol - Hospitalization

    Incidence of hospitalization due to pancreatic diseases caused by alcohol (K85.2, K86.0)

    Measured: January 1, 2016 to February 28, 2020

  10. Pancreatic diseases caused by alcohol - Death

    Death due to pancreatic diseases caused by alcohol (K85.2, K86.0)

    Measured: January 1, 2016 to February 28, 2020

  11. Gastritis caused by alcohol - Hospitalization

    Incidence of hospitalization due to gastritis caused by alcohol (K29.2)

    Measured: January 1, 2016 to February 28, 2020

  12. Gastritis caused by alcohol - Death

    Death due to gastritis caused by alcohol (K29.2)

    Measured: January 1, 2016 to February 28, 2020

  13. Alcoholic cardiomyopathy - Hospitalization

    Incidence of hospitalization due to alcoholic cardiomyopathy (I42.6)

    Measured: January 1, 2016 to February 28, 2020

  14. Alcoholic cardiomyopathy - Death

    Death due to alcoholic cardiomyopathy (I42.6)

    Measured: January 1, 2016 to February 28, 2020

  15. Nervous system disorders caused by alcohol - Hospitalization

    Incidence of hospitalization due to degeneration of the nervous system due to alcohol, epileptic seizures related to alcohol, alcoholic polyneuropathy, alcoholic myopathy (G312, G4051, G621, G721)

    Measured: January 1, 2016 to February 28, 2020

  16. Nervous system disorders caused by alcohol - Death

    Death due to degeneration of the nervous system due to alcohol, epileptic seizures related to alcohol, alcoholic polyneuropathy, alcoholic myopathy (G312, G4051, G621, G721)

    Measured: January 1, 2016 to February 28, 2020

  17. Alcohol poisoning - Hospitalization

    Incidence of hospitalization due to alcohol poisoning (T51, X45)

    Measured: January 1, 2016 to February 28, 2020

  18. Alcohol poisoning - Death

    Death due to alcohol poisoning (T51, X45)

    Measured: January 1, 2016 to February 28, 2020

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 May 2023
  2. Study start1 Jan 2015
  3. Primary completion28 Feb 2020
  4. Study completion30 Sep 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
3,950,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05865847
Sponsor's protocol ID
KKO-Inv 4-Johto-VPT-Terveysind
Status last verified
May 2023
First submitted
3 May 2023
Last updated
19 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The investigators will share the harmonization protocol to define the variables and the statistical code. Individual participant data is available upon request at FinData, following national data protection procedures.

Publications

  • GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018 Sep 22;392(10152):1015-1035. doi: 10.1016/S0140-6736(18)31310-2. Epub 2018 Aug 23.

    PubMed 30146330
  • Manthey J, Hassan SA, Carr S, Kilian C, Kuitunen-Paul S, Rehm J. What are the Economic Costs to Society Attributable to Alcohol Use? A Systematic Review and Modelling Study. Pharmacoeconomics. 2021 Jul;39(7):809-822. doi: 10.1007/s40273-021-01031-8. Epub 2021 May 10.

    PubMed 33970445
  • Room R, Ferris J, Laslett AM, Livingston M, Mugavin J, Wilkinson C. The drinker's effect on the social environment: a conceptual framework for studying alcohol's harm to others. Int J Environ Res Public Health. 2010 Apr;7(4):1855-71. doi: 10.3390/ijerph7041855. Epub 2010 Apr 21.

    PubMed 20617064
  • Probst C, Lange S, Kilian C, Saul C, Rehm J. The dose-response relationship between socioeconomic deprivation and alcohol-attributable mortality risk-a systematic review and meta-analysis. BMC Med. 2021 Nov 5;19(1):268. doi: 10.1186/s12916-021-02132-z.

    PubMed 34736475
  • Probst C, Kilian C, Sanchez S, Lange S, Rehm J. The role of alcohol use and drinking patterns in socioeconomic inequalities in mortality: a systematic review. Lancet Public Health. 2020 Jun;5(6):e324-e332. doi: 10.1016/S2468-2667(20)30052-9.

    PubMed 32504585
  • Syden L, Sidorchuk A, Makela P, Landberg J. The contribution of alcohol use and other behavioural, material and social factors to socio-economic differences in alcohol-related disorders in a Swedish cohort. Addiction. 2017 Nov;112(11):1920-1930. doi: 10.1111/add.13889. Epub 2017 Jul 17.

    PubMed 28556302
  • Makela P, Paljarvi T. Do consequences of a given pattern of drinking vary by socioeconomic status? A mortality and hospitalisation follow-up for alcohol-related causes of the Finnish Drinking Habits Surveys. J Epidemiol Community Health. 2008 Aug;62(8):728-33. doi: 10.1136/jech.2007.065672.

    PubMed 18621959
  • Pena S, Makela P, Laatikainen T, Harkanen T, Mannisto S, Heliovaara M, Koskinen S. Joint effects of alcohol use, smoking and body mass index as an explanation for the alcohol harm paradox: causal mediation analysis of eight cohort studies. Addiction. 2021 Aug;116(8):2220-2230. doi: 10.1111/add.15395. Epub 2021 Jan 28.

    PubMed 33404149
  • Katikireddi SV, Whitley E, Lewsey J, Gray L, Leyland AH. Socioeconomic status as an effect modifier of alcohol consumption and harm: analysis of linked cohort data. Lancet Public Health. 2017 May 10;2(6):e267-e276. doi: 10.1016/S2468-2667(17)30078-6. eCollection 2017 Jun.

    PubMed 28626829
  • Makela P. Alcohol-related mortality as a function of socio-economic status. Addiction. 1999 Jun;94(6):867-86. doi: 10.1046/j.1360-0443.1999.94686710.x.

    PubMed 10665076
  • Pena S, Makela P, Harkanen T, Heliovaara M, Gunnar T, Mannisto S, Laatikainen T, Vartiainen E, Koskinen S. Measurement error as an explanation for the alcohol harm paradox: analysis of eight cohort studies. Int J Epidemiol. 2021 Jan 23;49(6):1836-1846. doi: 10.1093/ije/dyaa113.

    PubMed 32995840
  • Sadler S, Angus C, Gavens L, Gillespie D, Holmes J, Hamilton J, Brennan A, Meier P. Understanding the alcohol harm paradox: an analysis of sex- and condition-specific hospital admissions by socio-economic group for alcohol-associated conditions in England. Addiction. 2017 May;112(5):808-817. doi: 10.1111/add.13726. Epub 2017 Feb 6.

    PubMed 27981670
  • Mackenbach JP, Kulhanova I, Bopp M, Borrell C, Deboosere P, Kovacs K, Looman CW, Leinsalu M, Makela P, Martikainen P, Menvielle G, Rodriguez-Sanz M, Rychtarikova J, de Gelder R. Inequalities in Alcohol-Related Mortality in 17 European Countries: A Retrospective Analysis of Mortality Registers. PLoS Med. 2015 Dec 1;12(12):e1001909. doi: 10.1371/journal.pmed.1001909. eCollection 2015 Dec.

    PubMed 26625134
  • Mackenbach JP. Should we aim to reduce relative or absolute inequalities in mortality? Eur J Public Health. 2015 Apr;25(2):185. doi: 10.1093/eurpub/cku217. No abstract available.

    PubMed 25818489

Questions about this trial

What is this clinical trial studying?

An observational study of Alcohol-Related Disorders, run by Finnish Institute for Health and Welfare.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 May 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Alcohol intoxication - Hospitalization (time frame: January 1, 2016 to February 28, 2020). The study lists 18 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05865847, which also lists 14 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in